<DOC>
	<DOCNO>NCT00442832</DOCNO>
	<brief_summary>The purpose study determine whether TD-1792 safe effective use treat complicate skin skin structure infection cause Gram-positive bacteria .</brief_summary>
	<brief_title>TD-1792 Gram-positive Complicated Skin Skin Structure Infection</brief_title>
	<detailed_description>TD-1792 compare vancomycin treatment cSSSI .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Skin Diseases , Infectious</mesh_term>
	<mesh_term>Staphylococcal Skin Infections</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<criteria>major abscess require surgical incision drainage , infected burn , deep/extensive cellulitis , infected ulcer , wound infection require least 7 day intravenous antibiotic treatment 24 hour antibiotic therapy moderate severe liver disease severely neutropenic baseline QTc &gt; 500 msec , congenital long QT syndrome , uncompensated heart failure , uncorrected abnormal K+ Mg++ blood level severe leave ventricular hypertrophy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>cSSSI</keyword>
	<keyword>Staph</keyword>
	<keyword>MRSA</keyword>
</DOC>